Overview

Study of Oglemilast for the Prevention of Asthma.

Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
0
Participant gender:
All
Summary
The purpose of this study is to determine whether it is effective in the treatment of exercise-induced asthma and investigate the safety of oglemilast.
Phase:
Phase 2
Accepts Healthy Volunteers?
No
Details
Lead Sponsor:
Forest Laboratories
Criteria
Inclusion Criteria:

- stable mild asthma patients who exhibit at least a 20% decrease in FEV1 following
exercise.

Exclusion Criteria:

- pulmonary disease other than asthma, psychiatric illness, active cardiac disease, high
blood pressure, history of substance abuse, current smokers.